Precancerous Lesions in Donor Organs; Dire Cancer Drug Shortage; CVD Ups Cancer Risk

A study of seemingly healthy donor pancreata revealed precancerous lesions in a majority of the organs. (American Association for Cancer Research)

The UChicago Medicine Comprehensive Cancer Center has joined the National Comprehensive Cancer Network, increasing the number of member institutions to 33.

Shortages of cancer drugs have created “dire circumstances” for some patients. (NBC News)

Mired in the complexities of bankruptcy, Clovis Oncology agreed to sell licensing rights for its PARP inhibitor rucaparib (Rubraca) to Austria-based pharma& Schwiez for $70 million. (BioPharma Dive)

China-based Shanghai Junshi Biosciences announced that its PARP inhibitor senaparib met the primary endpoint of a phase III trial in advanced ovarian cancer, extending progression-free survival in the maintenance setting.

Cardiovascular disease increases a person’s risk of developing cancer. (JACC: CardioOncology)

Women working in healthcare require better protection against radiation exposure to minimize the risk of breast cancer. (The BMJ)

Black patients with cancer have a significantly greater risk of chemotherapy-induced cardiotoxicity. (American College of Cardiology)

Mixed cancer findings from the first year of the COVID pandemic as compared with 2019: Fewer patients died of cancer as the primary cause but more died with cancer as a contributing factor. (American Cancer Society, Journal Oncology Practice)